Crohn’s Disease Treatment with Blood Stem Cells Shows No Sustained Benefits

Crohn’s Disease Treatment with Blood Stem Cells Shows No Sustained Benefits
Researchers in a new study analyzed the outcomes of a clinical trial comparing standard therapy with hematopoietic (blood) stem cell transplantation (HSCT) in Crohn’s disease patients and found that HSCT did not result in a statistically significant improvement over conventional therapy. The study, titled “Autologous Hematopoetic Stem Cell Transplantation for Refractory Crohn Disease: A Randomized Clinical Trial,” was

Knowledge is power when living with IBD.

Get access to the web’s leading IBD news & insights for as little as 16¢/day.
Subscribe or to access all post and page content.

Leave a Comment

Your email address will not be published. Required fields are marked *